140 related articles for article (PubMed ID: 621718)
1. Relationship between structure and antineoplastic activity of arylsulfonylhydrazones of 2-formylprydine N-oxide.
Agrawal KC; Sartorelli AC
J Med Chem; 1978 Feb; 21(2):218-21. PubMed ID: 621718
[TBL] [Abstract][Full Text] [Related]
2. Antineoplastic and biochemical properties of arylsulfonylhydrazones of 2-formylpyridine N-oxide.
Sartorelli AC; Agrawal KC; Booth BA; Pittman J; Bartholomew DG
J Med Chem; 1976 Jun; 19(6):830-3. PubMed ID: 181576
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antineoplastic activity of phenyl-substituted benzenesulfonylhydrazones of 2-pyridinecarboxyaldehyde 1-oxide.
Loh W; Cosby LA; Sartorelli AC
J Med Chem; 1980 Jun; 23(6):631-4. PubMed ID: 7392030
[TBL] [Abstract][Full Text] [Related]
4. Relationship between structure and antineoplastic activity of (arylsulfonyl)hydrazones of 4-pyridinecarboxaldehyde.
Shyam K; Cosby LA; Sartorelli AC
J Med Chem; 1985 Jan; 28(1):149-52. PubMed ID: 3965708
[TBL] [Abstract][Full Text] [Related]
5. Antineoplastic properties of arylsulfonylhdrazones of 3-formylpyridazine 2-oxide and 4-formylpyrimidine 3-oxide.
May JA; Sartorelli AC
J Med Chem; 1978 Dec; 21(12):1333-5. PubMed ID: 722747
[TBL] [Abstract][Full Text] [Related]
6. Potential antitumor agents. 14. 4-Substituted 2-formylpyridine thiosemicarbazones.
Agrawal KC; Booth BA; DeNuzzo S; Sartorelli
J Med Chem; 1976 Oct; 19(10):1209-14. PubMed ID: 994151
[TBL] [Abstract][Full Text] [Related]
7. Relationship of spontaneous chemical transformation of arylsulfonylhydrazones of 2-pyridinecarboxaldehyde 1-oxide to anticancer activity.
Shiba DA; May JA; Sartorelli AC
Cancer Res; 1983 May; 43(5):2023-9. PubMed ID: 6831433
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship of 3-substituted N-(pyridinylacetyl)-4- (8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene )- piperidine inhibitors of farnesyl-protein transferase: design and synthesis of in vivo active antitumor compounds.
Njoroge FG; Vibulbhan B; Rane DF; Bishop WR; Petrin J; Patton R; Bryant MS; Chen KJ; Nomeir AA; Lin CC; Liu M; King I; Chen J; Lee S; Yaremko B; Dell J; Lipari P; Malkowski M; Li Z; Catino J; Doll RJ; Girijavallabhan V; Ganguly AK
J Med Chem; 1997 Dec; 40(26):4290-301. PubMed ID: 9435898
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of potential anticancer agents: imidazo[4,5-c]pyridines and imidazo[4,5-b]pyridines.
Temple C; Rose JD; Comber RN; Rener GA
J Med Chem; 1987 Oct; 30(10):1746-51. PubMed ID: 3656351
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor activity of amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone.
Liu MC; Lin TS; Sartorelli AC
J Med Chem; 1992 Oct; 35(20):3672-7. PubMed ID: 1433178
[TBL] [Abstract][Full Text] [Related]
11. 1,2-Dihydropyrido[3,4-b]pyrazines: structure-activity relationships.
Temple C; Wheeler GP; Elliott RD; Rose JD; Comber RN; Montgomery JA
J Med Chem; 1983 Jan; 26(1):91-5. PubMed ID: 6827530
[TBL] [Abstract][Full Text] [Related]
12. 1-Amino-substituted 4-methyl-5H-pyrido[3',4':4,5]pyrrolo[3,2-c]pyridines: a new class of antineoplastic agents.
Nguyen CH; Bisagni E; Pepin O; Pierré A; de Cointet P
J Med Chem; 1987 Sep; 30(9):1642-7. PubMed ID: 3625709
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of nitrosourea derivatives of pyridine and piperidine as potential anticancer agents.
Crider AM; Lamey R; Floss HG; Cassady JM; Bradner WJ
J Med Chem; 1980 Aug; 23(8):848-51. PubMed ID: 7401113
[TBL] [Abstract][Full Text] [Related]
14. Phosphorus-nitrogen compounds. 22. Synthesis and antitumor activity of arylsulfonylhydrazone analogues.
Cates LA; Good DJ; Jones GS; Lemke TL
J Med Chem; 1978 Nov; 21(11):1146-9. PubMed ID: 722720
[TBL] [Abstract][Full Text] [Related]
15. Antimitotic agents: structure-activity studies with some pyridine derivatives.
Temple C; Rener GA; Waud WR; Noker PE
J Med Chem; 1992 Oct; 35(20):3686-90. PubMed ID: 1433180
[TBL] [Abstract][Full Text] [Related]
16. Potential antitumor agents. 5. Methylated -(N)-heterocyclic carboxaldehyde thiosemicarbazones.
Agrawal KC; Cushley RJ; Lipsky SR; Wheaton JR; Sartorelli AC
J Med Chem; 1972 Feb; 15(2):192-5. PubMed ID: 5008241
[No Abstract] [Full Text] [Related]
17. Potential bioreductive alkylating agents. 7. Antitumor effects of phenyl-substituted 2-chloromethyl-3-phenyl-1,4-naphthoquinones.
Lin AJ; Sartorelli AC
J Med Chem; 1976 Nov; 19(11):1336-8. PubMed ID: 1003413
[TBL] [Abstract][Full Text] [Related]
18. Antitumor amino-substituted pyrido[3',4':4,5]pyrrolo[2,3-g]isoquinolines and pyrido[4,3-b]carbazole derivatives: synthesis and evaluation of compounds resulting from new side chain and heterocycle modifications.
Rivalle C; Wendling F; Tambourin P; Lhoste JM; Bisagni E; Chermann JC
J Med Chem; 1983 Feb; 26(2):181-5. PubMed ID: 6827534
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activity of guanylhydrazones of 2- and 4-pyridine and 4-quinoline carboxaldehydes.
Foye WO; Almassian B; Eisenberg MS; Maher TJ
J Pharm Sci; 1990 Jun; 79(6):527-30. PubMed ID: 2395098
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cytotoxicity of some Mannich bases of various aryl and arylidene ketones and their corresponding arylhydrazones.
Dimmock JR; Advikolanu KM; Scott HE; Duffy MJ; Reid RS; Quail JW; Jia Z; Hickie RA; Allen TM; Rutledge JM
J Pharm Sci; 1992 Dec; 81(12):1147-52. PubMed ID: 1491328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
